Literature DB >> 27257852

Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab.

William F McIntyre1, Zardasht Oqab2, Geoffrey E J Seaborn3, Wilma M Hopman4, Nazik Hammad3, Adrian Baranchuk5.   

Abstract

Entities:  

Keywords:  Autonomic nervous system; Cardio-oncology; Heart rate variability; Hypertension; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2016        PMID: 27257852     DOI: 10.1016/j.ijcard.2016.05.061

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  1 in total

1.  Vascular Endothelial Growth Factor and Ischemic Heart Disease Risk: A Mendelian Randomization Study.

Authors:  Shiu Lun Au Yeung; Hugh Simon Hung San Lam; C Mary Schooling
Journal:  J Am Heart Assoc       Date:  2017-08-01       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.